Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaPhase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma, Published online: 16 November 2017; doi:10.1038/leu.2017.327

Source: Leukemia - November 16, 2017 Category: Hematology Authors: S Bringhen M D ’Agostino L De Paoli V Montefusco A M Liberati P Galieni S Grammatico V E Muccio F Esma C De Angelis P Musto S Ballanti M Offidani R M T Petrucci G Gaidano P Corradini A Palumbo P Sonneveld M Boccadoro Source Type: research